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Background:  Risk stratification schemes for stroke and thromboembolism in atrial fibrillation (AF) vary widely and have only limited predictive 
ability. There is no clear consensus about antithrombotic treatment particularly in patients with AF at low-intermediate risk. Transesophageal 
echocardiography (TEE) is useful for thromboembolic risk prediction in AF. 
Methods:  In 498 patients with nonvalvular AF (mean age 67 years, 363 men, mean follow-up 5.7±3.2 years) who underwent TEE, incidences 
of stroke, cardiac events (myocardial infarction or admission for heart failure) and mortality were evaluated. Left atrial abnormality (left atrial 
appendage flow velocity <20cm/sec, dense spontaneous echo contrast, or thrombi) and/or complex aortic plaque (mobile, ulcerated, pedunculate, 
or thickness >4mm) were examined by TEE. 
Results:  The incidences of stroke, cardiovascular events and mortality were higher in patients with CHADS2 score >2 than in those with CHADS2 
score <2. Similarly, stroke, cardiovascular events and mortality were higher in patients with TEE risk (left atrial abnormality and/or complex aortic 
plaque) than in those without. Among patients with CHADS2 score <2, ischemic stroke, cardiovascular events and mortality were significantly 
higher in patients with TEE risk than in those without (2.0 vs 0.5%/years, Hazards ratio (HR) 3.5, p<0.05; 4.7 vs 1.9%/years, HR 2.3, p<0.01; and 
4.7 vs 2.0%/years, HR 2.3, p<0.01; respectively). Among patients with CHADS2 score 0, ischemic stroke, cardiovascular events and mortality were 
significantly higher in patients with TEE risk compared to those without (1.7 vs 0.3%/years, p<0.05; 4.1 vs 1.6%/years, p<0.01; and 3.9 vs 1.4%/
years, p<0.01; respectively). On multivariate analysis, CHADS2 score >2 and TEE risk independently predicted cardiovascular events (HR 1.8, p<0.01 
and HR 2.8, p<0.01, respectively) and mortality (HR 1.6, p<0.01 and HR 1.7, p<0.01, respectively). 
Conclusions:  Combining TEE findings with CHADS2 score improved prognostic accuracy for ischemic stroke, cardiovascular events and mortality. 
TEE could detect patients with nonvalvular AF stratified at low-intermediate risk but should receive anticoagulation treatment.
